Early detection with IMMray™ PanCan-d

By early diagnosis – or early detection – of pancreatic cancer, we mean the detection of the cancer in stage I or stage II, when the cancer is still resectable by surgical procedure. Because of the nature and aggressivity of the disease, early diagnosis is by far the best hope for treatment and long-term control of pancreatic cancer.

There is currently no standard diagnostic tool or method for the early detection of pancreatic cancer. A test that is sensitive and specific enough to detect pancreatic cancer in its earliest stages has the potential of saving many lives.

Link to the latest Webinar on IMMray™ PanCan-d: Immunovia reports historical breakthrough in early detection of pancreatic cancer in high risk groups

Link to IMMray™ PanCan-d Commercial Test Model study poster

Link to IMMray™ PanCan-d Optimization study poster

Link to IMMray™ PanCan-d results published in Journal of Clinical Oncology. Flyer for download (Pdf).


Subscribe to receive press releases and reports via email
To start your subscription you need to activate your e-mail address by clicking the link in the email that is sent to you after you have submitted this form. Please check the junk mail if you cannot find the message.

Press releases
Financial reports